Parkinson's Disease Trial, By Invitation NCT07176091 Sponsor: Second Affiliated Hospital of Soochow University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT07176091
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 40 and 80 years old.
  • People who have been diagnosed with idiopathic Parkinson's disease according to specific 2015 diagnostic guidelines, with the condition present for at least 3 years, and not at the most severe stage of the disease (Hoehn & Yahr stage below 4).
  • People whose Parkinson's medications have remained at a stable dose for at least 2 weeks before the study begins, with no dose changes planned during the study.
  • People who also experience Parkinson's-related pain that occurs at least 3 times per week, has been ongoing for at least 3 months, and rates at 3 or higher on a standard pain scale from 0 to 10.
  • People who pass a safety screening questionnaire related to a brain stimulation procedure called TMS.
  • People who pass a safety screening questionnaire related to MRI scans.
  • People who provide written informed consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have other conditions that affect nerve sensation, such as diabetes, herpes infection, stroke, or spinal cord disorders.
  • People who have a serious depression or psychiatric condition alongside their Parkinson's diagnosis.
  • People with severe cognitive impairment, defined as scoring 9 or below on a standard memory and thinking test called the MMSE.
  • People who have structural brain lesions or a history of traumatic brain injury.
  • People with serious disease affecting the heart, liver, kidneys, or other vital organs.
  • People who are unable to have an MRI scan or receive TMS treatment due to reasons such as claustrophobia, having an implanted device like a pacemaker, a history of epilepsy, or other related safety concerns.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Second Affiliated Hospital of Soochow University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Assessment with the KPPS; Assessment with the MKPPS; Change in Pain Intensity Scores (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov